Open AccessManagement of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature
Author(s) -
Baksh Mizba,
Jiang Liuyan,
Bhatia Unnati,
Alegria Victoria,
Sher Taimur,
Roy Vivek,
ChananKhan Asher,
Ailawadhi Sikander,
Parrondo Ricardo D.
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5181
Subject(s) - lymphoplasmacytic lymphoma , medicine , lytic cycle , chemoimmunotherapy , waldenstrom macroglobulinemia , lymphoma , pathology , immunology , rituximab , virus
Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is often differentiated from myeloma based on the presence of lytic bone lesions (LBL). However, WM/LPL can present with LBL, and management is poorly understood. We describe a case of an 81‐year‐old woman with LPL who presented with LBL and was successfully treated with chemoimmunotherapy.